Safety of reconversion to calcineurin inhibitor (CNI) based immunosuppression in liver transplant recipients who had been converted to everolimus for post-transplant renal impairment
Citation
Dayangaç, M. (2018). Safety of reconversion to calcineurin inhibitor (CNI) based immunosuppression in liver transplant recipients who had been converted to everolimus for post-transplant renal impairment. Joint International Congress of ILTS, ELITA and LICAGE içinde (213-213. ss.). Lisbon, Portugal, 23-26 May 2018.Abstract
…
WoS Q Kategorisi
Q1Source
Joint International Congress of ILTS, ELITA and LICAGEVolume
102Issue
Supplement: 5Collections
- Bildiri Koleksiyonu [514]
- WoS İndeksli Yayınlar Koleksiyonu [6416]